Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

Erythropoietin to Prevent Transfusions in Premature Infants

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Kotto-Kome AC, Garcia MG, Calhoun DA, Christensen RD . Effect of beginning recombinant erythropoietin treatment within the first week of life, among very-low-birth-weight neonates, on “early” and “late” erythrocyte transfusions: a meta-analysis. J Perinatol 2004;24:24–29.

    Article  CAS  Google Scholar 

  2. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF . Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 1999;354:1896–1900.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Alfaleh, K., Thabane, L. Erythropoietin to Prevent Transfusions in Premature Infants. J Perinatol 25, 560 (2005). https://doi.org/10.1038/sj.jp.7211323

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jp.7211323

Search

Quick links